Table 2. Clinical characteristics, treatment, and prognosis information of GTN patients with liver or brain metastases (n=11)
Abbreviation: EMA: etoposide, methotrexate, dactinomycin; EP: etoposide/cisplatin; CO: cyclophosphamide/vincristine; FA:5-fluorouracil (5-FU), dactinomycin: β-hCG, β-human chorionic gonadotropin; TC: paclitaxel/carboplatin (Q3 weeks); TP: paclitaxel/cisplatin (Q3 weeks); TP/TE: paclitaxel, cisplatin/paclitaxel, etoposide; BEP: bleomycin, etoposide, cisplatin; MAC: methotrexate, dactinomycin, cyclophosphamide; GP: gemcitabine, cisplatin; ICE: ifosfamide, etoposide, cisplatin; FAV: floxuridine, actinomycin D, vincristine; IT MTX: intrathecal methotrexate; FIGO, International Federation of Gynecology and Obstetrics; CSF: cerebrospinal fluid; Early death: Death occurring within 4 weeks of treatment initiate; DOD, dead of disease; NED, no evidence of disease.